 | A1BQF | Name: | (3S)-1-[(4-chloro-2-methoxyphenyl)acetyl]piperidine-3-carboxamide | Formula: | C15 H19 Cl N2 O3 | SMILES: | O=C(Cc1ccc(Cl)cc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C15H19ClN2O3/c1-21-13-8-12(16)5-4-10(13)7-14(19)18-6-2-3-11(9-18)15(17)20/h4-5,8,11H,2-3,6-7,9H2,1H3,(H2,17,20)/t11-/m0/s1 | Definition date: | 2025-01-13 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(4-chloro-2-methoxyphenyl)acetyl]piperidine-3-carboxamide |
|
 | A1BQQ | Name: | 2-{(3R)-1-[(2-methoxyphenyl)acetyl]pyrrolidin-3-yl}acetamide | Formula: | C15 H20 N2 O3 | SMILES: | O=C(Cc1ccccc1OC)N1CCC(CC(N)=O)C1 | InChi: | InChI=1S/C15H20N2O3/c1-20-13-5-3-2-4-12(13)9-15(19)17-7-6-11(10-17)8-14(16)18/h2-5,11H,6-10H2,1H3,(H2,16,18) | Definition date: | 2025-01-13 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 2-{(3R)-1-[(2-methoxyphenyl)acetyl]pyrrolidin-3-yl}acetamide |
|
 | A1BQR | Name: | 1-methyl-N-(2,4,6-trimethylphenyl)-1H-pyrazol-3-amine | Formula: | C13 H17 N3 | SMILES: | Cn1ccc(Nc2c(C)cc(C)cc2C)n1 | InChi: | InChI=1S/C13H17N3/c1-9-7-10(2)13(11(3)8-9)14-12-5-6-16(4)15-12/h5-8H,1-4H3,(H,14,15) | Definition date: | 2025-01-13 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 1-methyl-N-(2,4,6-trimethylphenyl)-1H-pyrazol-3-amine |
|
 | A1BQU | Name: | 1-methyl-N-[2-(1,3-oxazol-4-yl)ethyl]-1H-pyrazolo[3,4-b]pyridine-3-carboxamide | Formula: | C13 H13 N5 O2 | SMILES: | Cn1nc(C(=O)NCCc2cocn2)c2cccnc21 | InChi: | InChI=1S/C13H13N5O2/c1-18-12-10(3-2-5-14-12)11(17-18)13(19)15-6-4-9-7-20-8-16-9/h2-3,5,7-8H,4,6H2,1H3,(H,15,19) | Definition date: | 2025-01-13 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 1-methyl-N-[2-(1,3-oxazol-4-yl)ethyl]-1H-pyrazolo[3,4-b]pyridine-3-carboxamide |
|
 | A1BQV | Name: | (3S)-1-[(1H-indol-7-yl)methyl]-6-oxopiperidine-3-carboxamide | Formula: | C15 H17 N3 O2 | SMILES: | NC(=O)C1CCC(=O)N(Cc2cccc3cc[NH]c23)C1 | InChi: | InChI=1S/C15H17N3O2/c16-15(20)12-4-5-13(19)18(9-12)8-11-3-1-2-10-6-7-17-14(10)11/h1-3,6-7,12,17H,4-5,8-9H2,(H2,16,20)/t12-/m0/s1 | Definition date: | 2025-01-13 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(1H-indol-7-yl)methyl]-6-oxopiperidine-3-carboxamide |
|
 | A1BRE | Name: | (3S)-N~1~-(3-methylphenyl)piperidine-1,3-dicarboxamide | Formula: | C14 H19 N3 O2 | SMILES: | O=C(Nc1cc(C)ccc1)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C14H19N3O2/c1-10-4-2-6-12(8-10)16-14(19)17-7-3-5-11(9-17)13(15)18/h2,4,6,8,11H,3,5,7,9H2,1H3,(H2,15,18)(H,16,19)/t11-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-(3-methylphenyl)piperidine-1,3-dicarboxamide |
|
 | A1BRF | Name: | (3S)-1-{[(4S)-3,4-dihydro-2H-1-benzopyran-4-yl]methyl}-6-oxopiperidine-3-carboxamide | Formula: | C16 H20 N2 O3 | SMILES: | NC(=O)C1CCC(=O)N(C1)CC1CCOc2ccccc21 | InChi: | InChI=1S/C16H20N2O3/c17-16(20)12-5-6-15(19)18(10-12)9-11-7-8-21-14-4-2-1-3-13(11)14/h1-4,11-12H,5-10H2,(H2,17,20)/t11-,12+/m1/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-{[(4S)-3,4-dihydro-2H-1-benzopyran-4-yl]methyl}-6-oxopiperidine-3-carboxamide |
|
 | A1BRQ | Name: | tert-butyl [(1R)-2-[(3S)-3-carbamoylpiperidin-1-yl]-1-(2-methoxyphenyl)-2-oxoethyl]carbamate | Formula: | C20 H29 N3 O5 | SMILES: | O=C(C(NC(=O)OC(C)(C)C)c1ccccc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C20H29N3O5/c1-20(2,3)28-19(26)22-16(14-9-5-6-10-15(14)27-4)18(25)23-11-7-8-13(12-23)17(21)24/h5-6,9-10,13,16H,7-8,11-12H2,1-4H3,(H2,21,24)(H,22,26)/t13-,16?/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | tert-butyl [(1R)-2-[(3S)-3-carbamoylpiperidin-1-yl]-1-(2-methoxyphenyl)-2-oxoethyl]carbamate |
|
 | A1BRR | Name: | (3S)-1-{[2-(methoxymethyl)phenyl]acetyl}piperidine-3-carboxamide | Formula: | C16 H22 N2 O3 | SMILES: | O=C(Cc1ccccc1COC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C16H22N2O3/c1-21-11-14-6-3-2-5-12(14)9-15(19)18-8-4-7-13(10-18)16(17)20/h2-3,5-6,13H,4,7-11H2,1H3,(H2,17,20)/t13-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-{[2-(methoxymethyl)phenyl]acetyl}piperidine-3-carboxamide |
|
 | A1BRU | Name: | 1-methyl-N-[2-(1,3-thiazol-4-yl)ethyl]-1H-indazole-3-carboxamide | Formula: | C14 H14 N4 O S | SMILES: | Cn1nc(C(=O)NCCc2cscn2)c2ccccc21 | InChi: | InChI=1S/C14H14N4OS/c1-18-12-5-3-2-4-11(12)13(17-18)14(19)15-7-6-10-8-20-9-16-10/h2-5,8-9H,6-7H2,1H3,(H,15,19) | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 1-methyl-N-[2-(1,3-thiazol-4-yl)ethyl]-1H-indazole-3-carboxamide |
|
 | A1BRV | Name: | (3S)-1-[(2,3-dihydro-1-benzofuran-7-yl)methyl]-5-oxopyrrolidine-3-carboxamide | Formula: | C14 H16 N2 O3 | SMILES: | NC(=O)C1CC(=O)N(C1)Cc1cccc2CCOc12 | InChi: | InChI=1S/C14H16N2O3/c15-14(18)11-6-12(17)16(8-11)7-10-3-1-2-9-4-5-19-13(9)10/h1-3,11H,4-8H2,(H2,15,18)/t11-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2,3-dihydro-1-benzofuran-7-yl)methyl]-5-oxopyrrolidine-3-carboxamide |
|
 | A1BRY | Name: | (3S)-1-[(5-fluoro-2-methoxyphenyl)acetyl]piperidine-3-carboxamide | Formula: | C15 H19 F N2 O3 | SMILES: | O=C(Cc1cc(F)ccc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C15H19FN2O3/c1-21-13-5-4-12(16)7-11(13)8-14(19)18-6-2-3-10(9-18)15(17)20/h4-5,7,10H,2-3,6,8-9H2,1H3,(H2,17,20)/t10-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(5-fluoro-2-methoxyphenyl)acetyl]piperidine-3-carboxamide |
|
 | A1BRZ | Name: | (3S)-1-[(2-methylpyridin-3-yl)acetyl]piperidine-3-carboxamide | Formula: | C14 H19 N3 O2 | SMILES: | O=C(Cc1cccnc1C)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C14H19N3O2/c1-10-11(4-2-6-16-10)8-13(18)17-7-3-5-12(9-17)14(15)19/h2,4,6,12H,3,5,7-9H2,1H3,(H2,15,19)/t12-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2-methylpyridin-3-yl)acetyl]piperidine-3-carboxamide |
|
 | A1BSA | Name: | (3S)-1-[(2-bromo-3-fluorophenyl)di(fluoro)acetyl]piperidine-3-carboxamide | Formula: | C14 H14 Br F3 N2 O2 | SMILES: | O=C(N1CCCC(C1)C(N)=O)C(F)(F)c1cccc(F)c1Br | InChi: | InChI=1S/C14H14BrF3N2O2/c15-11-9(4-1-5-10(11)16)14(17,18)13(22)20-6-2-3-8(7-20)12(19)21/h1,4-5,8H,2-3,6-7H2,(H2,19,21)/t8-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2-bromo-3-fluorophenyl)di(fluoro)acetyl]piperidine-3-carboxamide |
|
 | A1BSB | Name: | (2S)-4-[(2-methoxyphenyl)acetyl]morpholine-2-carboxamide | Formula: | C14 H18 N2 O4 | SMILES: | O=C(Cc1ccccc1OC)N1CC(OCC1)C(N)=O | InChi: | InChI=1S/C14H18N2O4/c1-19-11-5-3-2-4-10(11)8-13(17)16-6-7-20-12(9-16)14(15)18/h2-5,12H,6-9H2,1H3,(H2,15,18)/t12-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (2S)-4-[(2-methoxyphenyl)acetyl]morpholine-2-carboxamide |
|
 | A1BSE | Name: | (3S)-1-[(2H-1,3-benzodioxol-4-yl)acetyl]piperidine-3-carboxamide | Formula: | C15 H18 N2 O4 | SMILES: | NC(=O)C1CCCN(C1)C(=O)Cc1cccc2OCOc12 | InChi: | InChI=1S/C15H18N2O4/c16-15(19)11-4-2-6-17(8-11)13(18)7-10-3-1-5-12-14(10)21-9-20-12/h1,3,5,11H,2,4,6-9H2,(H2,16,19)/t11-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2H-1,3-benzodioxol-4-yl)acetyl]piperidine-3-carboxamide |
|
 | A1BSF | Name: | (3S)-1-[(2-ethylphenyl)acetyl]piperidine-3-carboxamide | Formula: | C16 H22 N2 O2 | SMILES: | O=C(Cc1ccccc1CC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C16H22N2O2/c1-2-12-6-3-4-7-13(12)10-15(19)18-9-5-8-14(11-18)16(17)20/h3-4,6-7,14H,2,5,8-11H2,1H3,(H2,17,20)/t14-/m0/s1 | Definition date: | 2025-01-14 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2-ethylphenyl)acetyl]piperidine-3-carboxamide |
|
 | A1BSQ | Name: | 1-methyl-N-[(3R)-oxolan-3-yl]-1H-indazole-3-carboxamide | Formula: | C13 H15 N3 O2 | SMILES: | O=C(NC1CCOC1)c1nn(C)c2ccccc12 | InChi: | InChI=1S/C13H15N3O2/c1-16-11-5-3-2-4-10(11)12(15-16)13(17)14-9-6-7-18-8-9/h2-5,9H,6-8H2,1H3,(H,14,17)/t9-/m1/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | 1-methyl-N-[(3R)-oxolan-3-yl]-1H-indazole-3-carboxamide |
|
 | A1BSR | Name: | N-[(1R,2S)-2-(hydroxymethyl)cyclopropyl]-1-methyl-1H-indazole-3-carboxamide | Formula: | C13 H15 N3 O2 | SMILES: | OCC1CC1NC(=O)c1nn(C)c2ccccc21 | InChi: | InChI=1S/C13H15N3O2/c1-16-11-5-3-2-4-9(11)12(15-16)13(18)14-10-6-8(10)7-17/h2-5,8,10,17H,6-7H2,1H3,(H,14,18)/t8-,10-/m1/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | N-[(1R,2S)-2-(hydroxymethyl)cyclopropyl]-1-methyl-1H-indazole-3-carboxamide |
|
 | A1BST | Name: | (3S)-1-[(2-aminopyridin-4-yl)acetyl]piperidine-3-carboxamide | Formula: | C13 H18 N4 O2 | SMILES: | O=C(Cc1ccnc(N)c1)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C13H18N4O2/c14-11-6-9(3-4-16-11)7-12(18)17-5-1-2-10(8-17)13(15)19/h3-4,6,10H,1-2,5,7-8H2,(H2,14,16)(H2,15,19)/t10-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(2-aminopyridin-4-yl)acetyl]piperidine-3-carboxamide |
|
 | A1BSU | Name: | (3S)-N~1~-[2-methoxy-6-(methylsulfanyl)phenyl]piperidine-1,3-dicarboxamide | Formula: | C15 H21 N3 O3 S | SMILES: | O=C(Nc1c(OC)cccc1SC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C15H21N3O3S/c1-21-11-6-3-7-12(22-2)13(11)17-15(20)18-8-4-5-10(9-18)14(16)19/h3,6-7,10H,4-5,8-9H2,1-2H3,(H2,16,19)(H,17,20)/t10-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-[2-methoxy-6-(methylsulfanyl)phenyl]piperidine-1,3-dicarboxamide |
|
 | A1BSY | Name: | (3S)-N~1~-(5-cyano-2-methoxyphenyl)piperidine-1,3-dicarboxamide | Formula: | C15 H18 N4 O3 | SMILES: | O=C(Nc1cc(C#N)ccc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C15H18N4O3/c1-22-13-5-4-10(8-16)7-12(13)18-15(21)19-6-2-3-11(9-19)14(17)20/h4-5,7,11H,2-3,6,9H2,1H3,(H2,17,20)(H,18,21)/t11-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-(5-cyano-2-methoxyphenyl)piperidine-1,3-dicarboxamide |
|
 | A1BSZ | Name: | (3S)-1-[(5-bromo-2-methoxypyridin-3-yl)acetyl]piperidine-3-carboxamide | Formula: | C14 H18 Br N3 O3 | SMILES: | O=C(Cc1cc(Br)cnc1OC)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C14H18BrN3O3/c1-21-14-10(5-11(15)7-17-14)6-12(19)18-4-2-3-9(8-18)13(16)20/h5,7,9H,2-4,6,8H2,1H3,(H2,16,20)/t9-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-1-[(5-bromo-2-methoxypyridin-3-yl)acetyl]piperidine-3-carboxamide |
|
 | A1BTB | Name: | (3S)-N~1~-(3-methylphenyl)-N~1~-[2-oxo-2-(piperidin-1-yl)ethyl]piperidine-1,3-dicarboxamide | Formula: | C21 H30 N4 O3 | SMILES: | O=C(N(CC(=O)N1CCCCC1)c1cc(C)ccc1)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C21H30N4O3/c1-16-7-5-9-18(13-16)25(15-19(26)23-10-3-2-4-11-23)21(28)24-12-6-8-17(14-24)20(22)27/h5,7,9,13,17H,2-4,6,8,10-12,14-15H2,1H3,(H2,22,27)/t17-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (3S)-N~1~-(3-methylphenyl)-N~1~-[2-oxo-2-(piperidin-1-yl)ethyl]piperidine-1,3-dicarboxamide |
|
 | A1BTC | Name: | (2S)-4-[(2-methoxyphenyl)acetyl]piperazine-2-carboxamide | Formula: | C14 H19 N3 O3 | SMILES: | O=C(Cc1ccccc1OC)N1CC(NCC1)C(N)=O | InChi: | InChI=1S/C14H19N3O3/c1-20-12-5-3-2-4-10(12)8-13(18)17-7-6-16-11(9-17)14(15)19/h2-5,11,16H,6-9H2,1H3,(H2,15,19)/t11-/m0/s1 | Definition date: | 2025-01-15 | Last modified: | 2025-02-21 | Release date: | 2025-02-26 | Identifier: | (2S)-4-[(2-methoxyphenyl)acetyl]piperazine-2-carboxamide |
|